Recall D-0646-2025

US Class II Ongoing · initiated 2025-08-29

Recalling firm

Fagron Compounding Services, KS

Product

bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226

Reason for recall

Lack of Assurance of Sterility

← All recalls